Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gleave

Showing results (691-700 of 839) with videos related to

Pageof 84
Sort By:
Urology Practice|May 5, 2023
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Lisa Newcomb, et al.
European Urology|January 15, 2019
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate CancerGillian Vandekerkhove, Werner J Struss, Matti Annala, et al.
Cell Communication and Signaling : CCS|September 19, 2019
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signalingDisharee Nath, Xiang Li, Claudia Mondragon, et al.
Nutrition and Cancer|November 7, 2022
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance StudyJeannette M Schenk, Menghan Liu, Marian L Neuhouser, et al.
Plos Medicine|July 3, 2019
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker NetworkAndrée-Anne Grosset, Véronique Ouellet, Christine Caron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2018
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate CancerMarine F Garrido, Nicolas J-P Martin, Matthieu Bertrand, et al.
Molecular Oncology|January 27, 2016
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progressionFrancesco Crea, Luca Quagliata, Agnieszka Michael, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate CancerArun A Azad, Stanislav V Volik, Alexander W Wyatt, et al.
The Journal of Clinical Investigation|December 18, 2019
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor modelsLucia Nappi, Adeleke H Aguda, Nader Al Nakouzi, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
Pageof 84

Showing results (691-700 of 839) with videos related to

Sort By:
Pageof 84
Urology Practice|May 5, 2023
Effect of Diagnostic Biopsy Practice Location on Grade/Volume Reclassification in Active Surveillance for Prostate Cancer: A Multicenter Analysis from the Canary PASS CohortAdrian J Waisman Malaret, Peter Chang, Lisa Newcomb, et al.
European Urology|January 15, 2019
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate CancerGillian Vandekerkhove, Werner J Struss, Matti Annala, et al.
Cell Communication and Signaling : CCS|September 19, 2019
Abi1 loss drives prostate tumorigenesis through activation of EMT and non-canonical WNT signalingDisharee Nath, Xiang Li, Claudia Mondragon, et al.
Nutrition and Cancer|November 7, 2022
Dietary Patterns and Risk of Gleason Grade Progression among Men on Active Surveillance for Prostate Cancer: Results from the Canary Prostate Active Surveillance StudyJeannette M Schenk, Menghan Liu, Marian L Neuhouser, et al.
Plos Medicine|July 3, 2019
Validation of the prognostic value of NF-κB p65 in prostate cancer: A retrospective study using a large multi-institutional cohort of the Canadian Prostate Cancer Biomarker NetworkAndrée-Anne Grosset, Véronique Ouellet, Christine Caron, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 17, 2018
Regulation of eIF4F Translation Initiation Complex by the Peptidyl Prolyl Isomerase FKBP7 in Taxane-resistant Prostate CancerMarine F Garrido, Nicolas J-P Martin, Matthieu Bertrand, et al.
Molecular Oncology|January 27, 2016
Integrated analysis of the prostate cancer small-nucleolar transcriptome reveals SNORA55 as a driver of prostate cancer progressionFrancesco Crea, Luca Quagliata, Agnieszka Michael, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2015
Androgen Receptor Gene Aberrations in Circulating Cell-Free DNA: Biomarkers of Therapeutic Resistance in Castration-Resistant Prostate CancerArun A Azad, Stanislav V Volik, Alexander W Wyatt, et al.
The Journal of Clinical Investigation|December 18, 2019
Ivermectin inhibits HSP27 and potentiates efficacy of oncogene targeting in tumor modelsLucia Nappi, Adeleke H Aguda, Nader Al Nakouzi, et al.
European Urology Focus|September 13, 2016
PTEN Loss as Determined by Clinical-grade Immunohistochemistry Assay Is Associated with Worse Recurrence-free Survival in Prostate CancerTamara L Lotan, Wei Wei, Carlos L Morais, et al.
Pageof 84